Dactinomycin Injection
Product Name: Dactinomycin Injection
Common Name: Dactinomycin
Strength: 0.5 mg vial
Description:
Dactinomycin Injection, also known as actinomycin D, is an antineoplastic (anti-cancer) medication classified under the actinomycin group. It works by inhibiting RNA synthesis and preventing cell replication, which leads to the death of rapidly dividing cancer cells. Dactinomycin is primarily used in the treatment of various cancers, including Wilms’ tumor, rhabdomyosarcoma, Ewing’s sarcoma, and testicular cancer, as well as for the management of gestational trophoblastic neoplasia.
Administered intravenously, Dactinomycin is often used as part of combination chemotherapy regimens. Due to its potent effects, it is typically reserved for use in specialized oncology settings.
Indications and Usage:
Dactinomycin Injection is indicated for:
- Treatment of pediatric cancers such as Wilms’ tumor and rhabdomyosarcoma.
- Management of Ewing’s sarcoma.
- Treatment of gestational trophoblastic neoplasia (choriocarcinoma).
- Management of metastatic testicular cancer.
- Adjuvant therapy in certain solid tumors.
- Part of combination chemotherapy regimens in various malignancies.
Features:
- Potent anti-cancer medication used to treat a variety of tumors.
- Inhibits RNA synthesis, thereby preventing cancer cell replication.
- Administered intravenously for systemic action.
- Used in combination chemotherapy protocols for enhanced efficacy.
- Particularly effective in pediatric oncology and sarcoma treatments.
Pack Size: Dactinomycin Injection is available in 1 vial.
Minimum Order Quantity: 3000 packs
Certification: WHO-GMP
